Based on our experience in designing and operating clinical trials for
a wide range of conventional medicines, such as synthetic drugs,
we provide customized clinical trial solutions optimized
for each drug's characteristics and its development stage.
We design and professionally conduct customized clinical trials to prove the efficacy and safety of innovative new drugs.
Based on our accumulated experience and expertise, we provide optimized clinical trial solutions throughout the entire cycle from the initial development stage to regulatory approval, enabling various innovative new drugs, including first-in-class and best-in-class drugs, to successfully enter the market.
We design and expertly conduct clinical trials specializing in improved new drugs to enhance the therapeutic value of existing drugs and strengthen their market competitiveness. We provide customized clinical trial solutions that reflect various development strategies, such as formulation improvements, optimization of administration methods and dosages, and the addition of new indications, to prove the clinical benefits of improved new drugs and increase the likelihood of successful regulatory approval and market entry.
We design and professionally conduct customized clinical trials to prove that generic drugs are of the same quality, efficacy, and safety as original drugs. Through bioequivalence (BE) trials and comparative clinical trials, we meet regulatory agency approval standards and provide optimized clinical trial solutions for the rapid market entry of generic drugs.
We provide customized clinical solutions tailored to the characteristics and development stages of various pharmaceuticals, including new drugs, improved new drugs, and generics. Based on the extensive experience of medical doctors, pharmacists, nurses, biotechnologists, and clinical statisticians, we systematically conduct clinical trials optimized for the characteristics of each pharmaceutical.
We efficiently and successfully conduct our clients' clinical trials based on our in-depth insight into the latest clinical trial trends and regulatory standards. We provide customized clinical solutions that consider the key elements of each type of drug, including the complexity of new drug development, disease-specific characteristics, demonstration of differentiation of improved new drugs, and bioequivalence testing of generics.
C&R supports the successful market entry of our clients' drugs through a data-driven strategic approach and systematic support from our team of experts.